94878-41-8

Basic information

• Product Name: 1-benzhydrylindoline-2,3-dione
• Synonyms: 1-benzhydrylindoline-2,3-dione;1H-Indole-2,3-dione, 1-(diphenylMethyl)-
• CAS NO: 94878-41-8
• Molecular Formula: C₂₁H₁₅NO₂
• Molecular Weight: 313.3493
• Mol File: 94878-41-8.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-benzhydrylindoline-2,3-dione(CAS DataBase Reference)
• NIST Chemistry Reference: 1-benzhydrylindoline-2,3-dione(94878-41-8)
• EPA Substance Registry System: 1-benzhydrylindoline-2,3-dione(94878-41-8)

Safety Data

• Hazardous Substances Data: 94878-41-8(Hazardous Substances Data)

Usage

Description

1-Benzhydrylindoline-2,3-dione is a complex chemical compound belonging to the indole family, known for its diverse biological activities. This derivative features a unique molecular structure that holds potential applications in pharmaceuticals, dyes, and materials. Its intriguing properties and potential for further research and development make it a promising candidate for the creation of new drugs and materials.

Uses

Used in Pharmaceutical Industry:
1-Benzhydrylindoline-2,3-dione is used as a pharmaceutical compound for its potential role in the development of new drugs. Its unique structure and properties contribute to its potential as a key component in medicinal chemistry.
Used in Dyes Industry:
In the dyes industry, 1-benzhydrylindoline-2,3-dione is used as a dye compound due to its unique molecular structure, which may offer novel coloring properties and applications in various dye formulations.
Used in Materials Science:
1-Benzhydrylindoline-2,3-dione is utilized in materials science for its potential to contribute to the development of new materials with specific properties. Its complex molecular structure may enable the creation of innovative materials with applications in various industries.
Due to the intricate nature of 1-benzhydrylindoline-2,3-dione's molecular structure, a comprehensive understanding of its synthesis, reactivity, and potential uses is still being explored, indicating that ongoing research and development will be crucial in unlocking its full potential across these industries.

Upstream product

• 91-56-5 indole-2,3-dione 
• 776-74-9 Bromodiphenylmethane 

Downstream Products

• 1373243-61-8 1-benzhydryl-3-(6-hydroxy-3H-spiro[benzofuran-2,1'-cyclopropan]-5-yl)indolin-2-one 
• 1373243-62-9 C₃₂H₂₅NO₃ 
• 1373243-60-7 1-benzhydryl-3-hydroxy-3-(6-hydroxy-3H-spiro[benzofuran-2,1'-cyclopropan]-5-yl)indolin-2-one 
• 1373242-42-2 3-[7-(benzyloxy)-2,3-dihydro-1,4-benzodioxin-6-yl]-1-(diphenylmethyl)-3-hydroxy-1,3-dihydro-2H-indol-2-one 
• 1373242-43-3 3-[7-(benzyloxy)-2,3-dihydro-1,4-benzodioxin-6-yl]-1-(diphenylmethyl)-1,3-dihydro-2H-indol-2-one 
• 1467104-84-2 (3S)-3-[7-(benzyloxy)-2,3-dihydro-1,4-benzodioxin-6-yl]-3-[(benzyloxy)methyl]-1-(diphenylmethyl)-1,3-dihydro-2H-indol-2-one 
• 1467104-85-3 (3S)-1-(diphenylmethyl)-3-(7-hydroxy-2,3-dihydro-1,4-benzodioxin-6-yl)-3-(hydroxymethyl)-1,3-dihydro-2H-indol-2-one 
• 1467104-86-4 (8S)-1'-(diphenylmethyl)-2,3-dihydrospiro[furo[2,3-g][1,4]benzodioxine-8,3'-indol]-2'(1'H)-one 
• 1259933-16-8 XEN-402 
• 1467104-89-7 3-[6-(benzyloxy)-1,3-benzodioxol-5-yl]-1-(diphenylmethyl)-3-hydroxy-1,3-dihydro-2H-indol-2-one 
• 1467104-90-0 3-[6-(benzyloxy)-1,3-benzodioxol-5-yl]-1-(diphenylmethyl)-1,3-dihydro-2H-indol-2-one 
• 1467104-91-1 (3S)-3-[6-(benzyloxy)-1,3-benzodioxol-5-yl]-3-[(benzyloxy)methyl]-1-(diphenylmethyl)-1,3-dihydro-2H-indol-2-one 
• 1467104-92-2 (3S)-1-(diphenylmethyl)-3-(6-hydroxy-1,3-benzodioxol-5-yl)-3-(hydroxymethyl)-1,3-dihydro-2H-indol-2-one 
• 1467104-93-3 (7S)-1'-(diphenylmethyl)spiro[furo[2,3-f][1,3]benzodioxole-7,3'-indol]-2'(1'H)-one 

Relevant articles and documents

ASYMMETRIC SYNTHESES FOR SPIRO-OXINDOLE COMPOUNDS USEFUL AS THERAPEUTIC AGENTS

This invention is directed to asymmetric syntheses of certain spiro-oxindole derivatives, which are useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.

USE OF SPIRO-OXINDOLE COMPOUNDS AS THERAPEUTIC AGENTS

This invention is directed to methods of using spiro-oxindole compounds of formula (I): wherein k, j, Q, R1, R2a, R2b, R2c, R2d, R3a, R3b, R3c, and R3d are as defined herein, as a stereoisomer, enantiomer, tautomer thereof or mixtures thereof; or a pharmaceutically acceptable salt, solvate or prodrug thereof, for the treatment and/or prevention of hypercholesterolemia, benign prostatic hyperplasia, pruritis and cancer.